O-005 Submaximal angioplasty alone vs. stenting plus angioplasty for symptomatic intracranial atherosclerotic disease - a propensity score matched comparative study with long term follow-up

ConclusionSubmaximal angioplasty alone results in better long-term clinical outcomes in terms of stroke/TIA when compared with stenting and angioplasty for symptomatic intracranial atherosclerotic disease, and represents a potentially promising intervention.Abstract O-005 Table 1Procedural outcomes and patient follow-up dichotomized by submaximal angioplasv vs. stenting and angioplasty after propensity score matchingDisclosures A. Baig: None. A. Aguirre: None. B. Donnelly: None. C. Kuo: None. M. Kruk: None. J. Im: None. N. Joseph: None. C. Palka: None. A. Maini: None. E. Hashmi: None. J. Lim: None. R. Turner: None. P. Lai: None. K. Raygor: None. A. Siddiqui: 2; C; Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, and others. 4; C; Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc, and others. 6; C; National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; MicroVention FRED Trial & CONFIDENCE Study; and others. E. Levy: 2; C; Claret Medical, GLG Consulting, Guidepoint Global, Imperial Care, Medtronic, Rebound, StimMed, Misionix, Mosiac, Clarion, IRRAS.. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care, ...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: SNIS 20th annual meeting oral abstracts Source Type: research